GSK to pay Nabi third milestone for PentaStaph
ROCKVILLE, Md. Nabi Biopharmaceuticals will receive an $8 million payment from British drug maker GlaxoSmithKline following a technology transfer related to a bacterial vaccine, Nabi said Tuesday.
GSK Biologicals will make the payment following the transfer of program expertise associated with the sale of PentaStaph (pentavalant Staphylococcus aureus vaccine), which Nabi sold to GSK for $46 million, including $26 in milestone payments. The expected $8 million is the third of four milestones. The fourth, a payment of $5 million, will be paid upon completion of an early-stage clinical trial of the vaccine that began in December, expected in the next nine months.
“We have made tremendous progress in achieving the PentaStaph milestones by completing three of the four milestone tasks in eight short months following the close of this transaction,” Nabi president and CEO Raafat Fahim said. “We have one remaining milestone task to complete under this agreement before fully realizing the significant value of the PentaStaph asset sale.”
PositiveID files patent for Insulin Tracker
DELRAY BEACH, Fla. A company that develops healthcare and information management products has applied for a patent for an insulin-pen tracking and recording device.
PositiveID announced Monday that it had filed for a patent for the Insulin Tracker with the U.S. Patent and Trademark Office. The device slides onto insulin pens and allows diabetes patients to track and record the amount of insulin they inject, including the time and date of each injection, transmitting it to PositiveID’s iGlucose System database and allowing patients and their healthcare providers to monitor compliance.
“Due to the cumbersome nature of manually recording blood glucose levels, insulin dosages and the appropriate dates and times for each, many patients’ diabetes logs are incomplete or even nonexistent, which directly impacts patient compliance,” PositiveID chairman and CEO Scott Silverman said.
Milwaukee Health Services taps new corporate communications specialist
MILWAUKEE, Wis. Milwaukee Health Services, which owns and operates a retail-based convenient care clinic here, has hired Clarene Mitchell as corporate communications specialist.
In her new role, Mitchell’s duties will include advancing the organization’s public image, facilitating business and government partnerships, fundraising strategy efforts and special projects.
An initial area of concentration will focus on increasing the public image and utilization of MHSI’s Convenient Care Clinic that operates in the Midtown Piggly Wiggly supermarket. MHSI opened the clinic in October 2009 in partnership with Managed Health Services. The clinic, which is owned and operated by MHSI, was the first retail based clinic to be opened by a Federally Qualified Health Center on a national basis, the company stated.
Mitchell most recently worked with VITAS Innovative Hospice Care. Her professional history includes managing programs and public relations interests for Black Health Coalition of Wisconsin. Prior to that she was a health communications officer for the Milwaukee Health Department, the health and education liaison for Mayor John O. Norquist, in addition to other roles with such organizations as Sojourner Truth House, American Lung Association, Lisbon Avenue Neighborhood Development and the Milwaukee Urban League.